4.5 Article

Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom

Journal

EPIDEMIOLOGY AND INFECTION
Volume 137, Issue 1, Pages 38-47

Publisher

CAMBRIDGE UNIV PRESS
DOI: 10.1017/S0950268808000678

Keywords

-

Funding

  1. Sanofi Pasteur MSD

Ask authors/readers for more resources

Recent information on epidemiology and management of herpes zoster (HZ) and post-herpetic neuralgia (PHN), a painful complication of HZ, is scarce. The objective of this study was to document the burden of HZ and PHN in the United Kingdom. This retrospective analysis of the UK General Practice Research Database aimed to estimate HZ incidence and proportion of HZ patients developing PHN and to assess management costs in immunocompetent individuals aged,>= 50 years. A cohort of 27 225 HZ patients was selected.. corresponding to an incidence of 5-23/1000 person-years. Respectively 19-5 % and 13-7 % of patients developed PHN at least I and 3 months after HZ diagnosis. Mean direct cost was is an element of 103 per HZ patient and is an element of 341 and is an element of 397 per PHN episode (1- and 3-month definition respectively). Both HZ and PHN costs increased markedly with pain severity. This Study confirms that HZ and PHN are frequent and costly diseases in the United Kingdom.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available